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Abstract
Objective—The Wnt/β-catenin signaling pathway has been implicated in human heart valve 
disease and is required for early heart valve formation in mouse and zebrafish. However, the 
specific functions of Wnt/β-catenin signaling activity in heart valve maturation and maintenance in 
adults have not been previously determined.
Approach and Results—Here, we show that Wnt/β-catenin signaling inhibits Sox9 nuclear 
localization and proteoglycan expression in cultured chicken embryo aortic valves (AoVs). Loss 
of β-catenin in vivo in mice, using Periostin(Postn)Cre-mediated tissue-restricted loss of β-catenin 
(Ctnnb1) in valvular interstitial cells (VICs), leads to the formation of aberrant chondrogenic 
nodules and induction of chondrogenic gene expression in adult AoVs. These nodular cells 
strongly express nuclear Sox9, and Sox9 downstream chondrogenic extracellular matrix (ECM) 
genes, including Aggrecan, Col2a1, and Col10a1. Excessive chondrogenic proteoglycan 
accumulation and disruption of stratified ECM maintenance in the AoV leaflets are characteristics 
of myxomatous valve disease. Both in vitro and in vivo data demonstrate that loss of Wnt/β-
catenin signaling leads to increased nuclear expression of Sox9 concomitant with induced 
expression of chondrogenic ECM proteins.
Conclusions—β-catenin limits Sox9 nuclear localization and inhibits chondrogenic 
differentiation during valve development and in adult AoV homeostasis.
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Introduction
Adult heart valves are stratified into extracellular matrix (ECM) compartments, defined as 
collagen-rich fibrosa, proteoglycan-rich spongiosa, and elastin-rich ventricularis/atrialis 
layers.1 In diseased heart valves, disruption of ECM layers and deposition of abnormal 
matrix leads to valve dysfunction. Myxomatous valve disease is characterized by excessive 
proteoglycan accumulation and degradation of collagen and elastin fibers, leading to valve 
prolapse and insufficiency.1–4 The proteoglycan-rich spongiosa is similar to the ECM of 
cartilage, and regulatory pathways that control chondrogenesis also are active in valve 
development.1, 5, 6 Although dysregulation and reactivation of early developmental 
programs has been described in heart valve disease,7–11 it remains unclear whether the 
expansion of proteoglycan-rich spongiosa in myxomatous valve disease is an active 
chondrogenic process.
During the initiation of heart valve development, Wnt/β-catenin signaling is required for 
early endocardial cushion formation.12, 13 At later stages, Wnt/β-catenin promotes the 
expression of fibrosa-related and osteogenic-like ECM genes in cultured chicken embryo 
valve interstitial cells (VICs).14 Wnt/β-catenin signaling is active in normal heart valves in 
mice at 1 month of age and also is increased in human calcific aortic valve disease.14, 15 
Together, these data suggest that Wnt/β-catenin signaling has multiple roles in valve 
development and disease. However, the specific regulatory requirements for Wnt/β-catenin 
signaling in valvular ECM stratification and maintenance have not been previously 
reported.1, 6
Sox9, a SRY transcription factor required for cartilage lineage development,16–18 is crucial 
for normal valve formation and promotes expression of cartilage-associated genes.19, 20 In 
addition, Sox9 is required to prevent calcification in adult aortic valves (AoVs).21, 22 In 
diseased human and mouse heart valves,10, 11, 23, 24 expression of Sox9 and cartilage-related 
genes is induced, suggesting that induction of a chondrogenic gene program contributes to 
heart valve disease. In endochondral bone development, Wnt/β-catenin signaling inhibits 
Sox9-driven chondrogenesis and promotes osteogenic differentiation.25 However, whether 
reduction of Wnt/β-catenin signaling directly promotes Sox9-mediated proteoglycan 
expansion in normal heart valves or in myxomatous valve disease remains untested.
Here, we used embryonic chicken aortic valve organ cultures to investigate the role of 
Wnt/β-catenin signaling in layer-specific ECM expression during valve stratification. In 
vivo, we used VIC-specific loss of β-catenin driven by PostnCre26 in mice to determine 
requirements for β-catenin in valve ECM maturation and adult homeostasis. We show that 
Wnt/β-catenin limits Sox9 nuclear localization and inhibits chondrogenic differentiation of 
aortic VIC during heart valve development and maintenance in adults. Moreover, loss of β-
catenin in mice leads to the formation of hypertrophic nodules with excessive proteoglycan 
accumulation in adult AoV leaflets, and similarly increased nuclear localization of Sox9 and 
proteoglycan expression are observed in human myxomatous valve disease.
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Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Wnt/β-catenin signaling inhibits chondrogenic gene expression in cultured chicken aortic 
valves
Previously, we reported that Wnt3a treatment induces early osteogenic gene induction in 
cultured dissociated chicken embryonic day (E)14 aortic VICs.14 However, these dissociated 
cells do not retain the structural architecture of stratified heart valve leaflets, and therefore 
ECM compartmentalization cannot be examined using this method. In order to analyze 
diversified ECM production and regulation in a more physiological context, a novel aortic 
valve organ culture (aVOC) was devised. Whole aortic valves including adjacent aortic root 
were isolated from E14 chicken embryos and cultured in vitro as aVOCs. Although valve 
morphology is abnormal in cultured aVOCs, ECM compartmentalization is maintained, as 
shown by Movat’s Pentachrome staining of proteoglycans, collagen fibers and elastin, as 
well as immunostaining for Elastin (ventricularis), Aggrecan and Collagen 2 (Col2) 
(spongiosa), and also Col3 (fibrosa) (Fig. SIA–D). Thus, this system can be used for 
examination of regulatory mechanisms that control ECM compartmentalization in 
developing valves.
The role of Wnt/β-catenin signaling in heart valve ECM composition and 
compartmentalization was examined using the E14 chicken aVOC cultures. Cultures were 
treated with BIO to increase Wnt/β-catenin signaling,27 or XAV-939 to decrease Wnt/β-
catenin signaling.28 When treated with BIO (Wnt activation), the proteoglycan-expressing 
area, as indicated by Alcian Blue staining, decreases compared to vehicle-treated controls 
(DMSO) (Fig. SII). Although the area of proteoglycan expression was not increased in 
XAV-939-treated cultures, increased intensity of Alcian Blue staining was noted (Fig. SIIC). 
In contrast, XAV-939 treatment, but not BIO, decreases the fibrillar collagen-expressing 
area in cultured aVOC as indicated by Saffron staining (Fig. SII). Thus Wnt/β-catenin 
signaling inhibits proteoglycan expression (spongiosa) and is required for collagen 
expression (fibrosa) in cultured aVOCs. Immunostaining for the chondrogenic transcription 
factor Sox9 demonstrates that Sox9 protein expression is decreased in cultured aVOCs upon 
BIO treatment, whereas XAV-939 addition promotes Sox9 expression and nuclear 
localization (Fig. 1A–C). Expression of cartilage matrix proteins Aggrecan and Col2 also 
are repressed by BIO (Fig. 1E, H) and increased with XAV-939 (Fig. 1F, I). Quantification 
of gene expression by qRT-PCR confirms Wnt activation with BIO treatment, as indicated 
by increased Axin2 gene expression. Likewise BIO treatment dampens Col2a1 expression 
but has no apparent effect on Sox9, Col10, or Aggrecan gene expression levels. By contrast, 
Wnt inhibition with XAV-939 induces chondrogenic markers Sox9 and Aggrecan, but not 
Col2a1 (Fig. 1J). The differing effects of altered Wnt signaling on chondrogenic protein 
versus mRNA expression support complex downstream transcriptional and post-
transcriptional regulatory mechanisms. However, together, these data support a role for 
Wnt/β-catenin in ECM compartmentalization by limiting nuclear localization of Sox9 and 
expression of chondrogenic matrix proteins.
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Loss of β-catenin in aortic VICs results in formation of proteoglycan rich nodules in adult 
mice
The role of Wnt/β-catenin signaling in adult valves in vivo was examined in mice with loss 
of β-catenin in VICs. Wnt/β-catenin signaling is active in semilunar valves before birth as 
previously reported,14 and also at 2 weeks and in adult aortic valves as indicated by an 
Axin2lacZ/+ reporter line29 (Fig. 2A, SIII). Interestingly, Wnt/β-catenin signaling is active 
preferentially at the distal tip and the hinge of the AoV at 2 weeks after birth and also in 
adult mice. PostnCre26 was used for conditional recombination of floxed exons 2–6 in the β-
catenin allele30 (Ctnnb1fl/fl), and is active in AoV interstitial cells but not endothelium, as 
indicated by positive X-gal staining in adult PostnCre;ROSA26 mice (Fig. SIVB).31
The efficacy of PostnCre-mediated loss of β-catenin protein was determined in semilunar 
valves of PostnCre;Ctnnb1fl/fl mice at post-natal day (P)0 and 2 weeks of age. β-catenin 
protein expression is reduced in the AoV interstitium, but not endothelium, of 
PostnCre;Ctnnb1fl/fl mice at P0 and is not detectable at 2 weeks, compared to Cre-negative 
controls (Fig. SVA–D). Furthermore, Axin2 mRNA, a downstream target of Wnt/β-catenin 
signaling, is significantly decreased by ~70% in PostnCre;Ctnnb1fl/fl animals, compared to 
Cre-negative controls, in isolated AoV leaflets at 3 months of age (Fig. SVE). Therefore, β-
catenin protein and canonical Wnt signaling are reduced in the AoV interstitium of 
PostnCre;Ctnnb1fl/fl mice. Although β-catenin protein is reduced, the PostnCre;Ctnnb1fl/fl 
mice have apparently normal semilunar valve morphology at P0 (Fig. SVIA–D) and initial 
compartmentalization of collagen and proteoglycan as indicated by Pentachrome staining 
(Fig. SVIE–F). No differences in cell density or morphometry were observed at early 
postnatal stages (Fig SVIG, H). In addition, PostnCre;Ctnnb1fl/fl mice survive through 
gestation and do not exhibit obvious morbidity or mortality.
The requirement for β-catenin in valve homeostasis and ECM maintenance was determined 
in adult PostnCre;Ctnnb1fl/fl mice. Histological analysis of PostnCre;Ctnnb1fl/fl animals 
demonstrates that proteoglycan-rich nodules containing hypertrophic cells are present in the 
AoV at 2 months, with 100% penetrance at 3 months (Fig. 2B). Cre-mediated recombination 
occurs throughout the valve leaflets, as apparent in PostnCre;Ctnnb1fl/fl;ROSA26lacZ 
reporter mice at 3 months (Fig. 2B). However, the nodules are restricted to the distal tip of 
the AoV leaflet where Wnt/β-catenin signaling is active, as indicated by Axin2lacZ 
expression (Fig 2A). The formation of proteoglycan-rich nodules is specific to the semilunar 
valves with a lower frequency of nodule formation in the pulmonary valve and no apparent 
abnormalities noted in the mitral or tricuspid valves in PostnCre;Ctnnb1fl/fl animals up to 6 
months of age (Fig. SVII).
To visualize the morphology and stratification of the AoV, Movat’s Pentachrome and 
Masson’s Trichrome staining were performed. In controls, the AoV is stratified with defined 
layers of proteoglycans and collagen (Fig. 2C, E). However, all 3-month-old 
PostnCre;Ctnnb1fl/fl mice exhibit large nodules almost exclusively in the distal tip of the 
AoV (Fig. 2D, F). These nodules in PostnCre;Ctnnb1fl/fl AoVs are densely stained by 
Alcian Blue, indicating strong proteoglycan deposition (Fig. 2D). By contrast, fibrillar 
collagen deposition is apparently reduced in the nodules (Fig. 2F), but accumulation is 
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obvious surrounding the nodules, as indicated by Masson’s Trichrome staining. Strikingly, 
the nodular cells also exhibit dramatic morphological changes including the presence of 
hypertrophic cells (Fig. 2B, D, F). However, cell death was not apparent in the nodules of 
PostnCre;Ctnnb1fl/fl animals, as indicated by cleaved caspase-3 immunoreactivity (Fig. 
SVIII). In addition, the PostnCre;Ctnnb1fl/fl nodules do not calcify at 1 year of age (data not 
shown). The increased proteoglycan deposition and hypertrophic cellular morphology of the 
nodular cells in PostnCre;Ctnnb1fl/fl AoVs at 3 months are similar to hypertrophic 
chondrocytes.18 Thus β-catenin is required for normal ECM maintenance, and loss of β-
catenin leads to the formation of hypertrophic cartilage-like nodules in the adult AoV.
Aortic valve nodules express chondrogenic genes as a result of loss of β-catenin
Spongiosa and fibrosa ECM compartmentalization, as well as induction of chondrogenic 
regulatory mechanisms, were examined in PostnCre;Ctnnb1fl/fl AoV nodules. Sox9 is 
required for chondrogenesis,18 and for the expression of Hyaluronan and Proteoglycan Link 
protein 1 (Hapln1) in developing heart valves.32, 33 Hapln1 is normally restricted to the 
ventricularis side of Cre-negative control AoVs (Fig. 3A, C), but its expression is expanded 
throughout the proteoglycan-rich nodules in PostnCre;Ctnnb1fl/fl AoVs, as detected by 
immunofluorescent staining (Fig. 3B, C). Likewise, the transcription factor Sox9 is strongly 
expressed in the nuclei of nodular cells at the distal tip of AoV in PostnCre;Ctnnb1fl/fl 
animals (Fig. 3B, C), and the percentage of Sox9 positive nuclei is higher in the nodules 
compared to either peri-nodular areas or entire AoV leaflets in Cre-negative controls (Fig. 
3D). Thus, loss of β-catenin leads to increased nuclear Sox9 expression in proteoglycan-rich 
nodular cells in the adult AoV. Similarly, nuclear localization of Sox9 and increased Hapln1 
expression also are apparent in human myxomatous mitral valve disease (Fig. SIX).
The expression of Sox9 target genes Aggrecan (Acan), Col2, and ColX, which are expressed 
in cartilage, was examined in AoV lacking β-catenin. Both Aggrecan and Col2 are strongly 
expressed in the nodules of PostnCre;Ctnnb1fl/fl AoVs (Fig. 4B, E), in contrast to no 
detectable expression in the distal tip of AoV in Cre-negative controls (Fig. 4A, D). 
Consistent with the morphology similar to hypertrophic cartilage (Fig. 2F, H), the nodular 
cells in PostnCre;Ctnnb1fl/fl AoVs also express ColX (Fig. 4H), which is a hypertrophic 
chondrocyte marker18 and is not normally expressed in heart valves (Fig. 4G). Likewise, 
qRT-PCR analysis of gene expression demonstrates that Acan is increased by 33-fold (Fig. 
4C), Col2a1 by ~260-fold (Fig. 4F) and Col10a1 by ~700-fold (Fig. 4I) in 
PostnCre;Ctnnb1fl/fl AoVs compared to controls. Thus loss of β-catenin leads to induction 
of a chondrogenic gene program apparent in increased nuclear localization of Sox9 and 
induced expression of downstream target genes Acan, Col2a1, Hapln1, and Col10a1.
The proteoglycan composition and timing of induction were further examined in 
PostnCre;Ctnnb1fl/fl AoVs. Versican (Vcan) is normally the predominant proteoglycan in 
the spongiosa layer of AoVs (Fig. 4J), but is dramatically reduced in the nodules of 
PostnCre;Ctnnb1fl/fl AoVs, demonstrating a switch in the predominant proteoglycan to 
Aggrecan, with loss of β-catenin (Fig. 4K). Consistent with the transition to a chondrogenic 
ECM, the expression of Hapln1 expands markedly to encompass the entire nodule in 
PostnCre;Ctnnb1fl/fl AoVs (Fig. 4K). qRT-PCR analysis also demonstrates that Hapln1 is 
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increased by 8-fold and Vcan is decreased by 60% (Fig. 4L). The initiation of nodule 
formation and proteoglycan alterations were examined at early post-natal stages. At P0 and 
2 weeks, Aggrecan, not normally expressed in mouse aortic valves, is detected in 
PostnCre;Ctnnb1fl/fl AoVs (Fig. SXB, D). Other chondrogenic ECM markers including 
Col2 and ColX are not expressed in PostnCre;Ctnnb1fl/fl AoV at this early stage, indicating 
that formation of the hypertrophic nodules develops over time. Thus, loss of β-catenin leads 
to induction of proteoglycans and collagens characteristic of cartilage, beginning with 
Aggrecan. Together, these data suggest that loss of β-catenin drives VICs in 
PostnCre;Ctnnb1fl/fl AoVs to undergo progressive chondrogenic differentiation and 
maturation after birth.
The fibrosa ECM is dysregulated in adult AoV lacking β-catenin
The initial formation and compartmentalization of the fibrosa layer relative to the spongiosa 
was examined in PostnCre;Ctnnb1fl/fl AoVs at P0 and 2 weeks. The initial organization of 
collagen and proteoglycan-rich regions of semilunar valves is apparently normal, as 
indicated by Movat’s pentachrome staining (Fig. SVIE, F). Localized expression of Col1 
and Hapln1 also is apparently normal at 2 weeks in both PostnCre;Ctnnb1fl/fl animals and 
Cre-negative controls (Fig. SXG, H). In adult mice, Col1 expression normally is restricted to 
the fibrosa layer (Fig. 5A). However, this well-defined layer is lost in PostnCre;Ctnnb1fl/fl 
AoVs, in which Col1 is absent from the nodules but is apparent in the peri-nodular areas 
(Fig. 5B). Likewise, Col3 is predominantly expressed in the fibrosa layer in Cre-negative 
control AoVs (Fig. 5C). However, in PostnCre;Ctnnb1fl/fl AoVs, Col3 expression is 
expanded throughout the thickened leaflets but is only minimally expressed in the 
proteoglycan-rich nodules (Fig. 5D). Consistent with the expression of Col1 and Col3, 
endogenous Postn is not detected within the nodules of PostnCre;Ctnnb1fl/fl animals, but is 
expressed in the thickened distal tip in the collagen-rich region (Fig. 5E, F). In addition, 
Col1a1 and Postn transcripts are significantly decreased in PostnCre;Ctnnb1fl/fl AoVs, 
compared to Cre-negative controls (Fig. 5G), at 3 months. Thus, the proteoglycan rich 
nodules lose the expression of fibrillar collagens and matricellular Postn, while the fibrosa 
layer is disrupted in adult PostnCre;Ctnnb1fl/fl AoVs. Together, these data demonstrate that 
loss of β-catenin signaling disrupts normal ECM maintenance and compartmentalization in 
the adult AoV.
Discussion
β-catenin is required for endothelial-to-mesenchymal transition at the early endocardial 
cushion stage in heart valve development,13 and upregulation of Wnt/β-catenin signaling has 
been implicated in heart valve disease.15 Here, we show that β-catenin signaling is required 
for normal ECM maintenance and heart valve homeostasis in cultured embryonic chicken 
aortic valves and adult mice. In vitro and in vivo analyses demonstrate increased nuclear 
localization of Sox9 and induction of downstream chondrogenic gene expression when 
Wnt/β-catenin signaling is reduced. Thus, Wnt/β-catenin signaling limits nuclear localization 
of Sox9 in aortic VICs and is required for maintenance of ECM compartmentalization. 
These regulatory interactions are intrinsic to VICs, since PostnCre is not active in 
endothelial cells and β-catenin expression is maintained on the surface of 
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PostnCre;Ctnnb1fl/fl AoVs. Together, these studies demonstrate a critical role for Wnt/β-
catenin signaling in heart valve ECM homeostasis with implications for myxomatous valve 
disease mechanisms (see model, Fig SXI).
Embryonic aVOC cultures treated with the Wnt/β-catenin activator BIO have decreased 
proteoglycan deposition, whereas treatment with the inhibitor XAV leads to increased 
chondrogenic matrix protein expression and nuclear localization of Sox9. Likewise, 
treatment of isolated embryonic aortic VICs with Wnt3a induces fibrosa-like gene 
expression consistent with a role in heart valve ECM compartmentalization.14 However, the 
initial stratification of PostnCre;Ctnnb1fl/fl AoVs is normal at 2 weeks of age, indicating that 
Wnt/β-catenin signaling is not required for initiation of valve stratification, but rather for 
maintenance of normal ECM compartmentalization. Further evidence for active Wnt/β-
catenin signaling in adult valve homeostasis is the expression of a Axin2lacZ/+ reporter in the 
distal regions of adult AoV and reduction of Axin2 transcripts in PostnCre;Ctnnb1fl/fl AoVs. 
Interestingly, the formation of hypertrophic cartilage-like nodules in PostnCre;Ctnnb1fl/fl 
mice also occurs at the distal tips of the AoVs. The lack of an initial effect on valve 
stratification and the localization of the chondrogenic nodules to the distal tips of the aortic 
valve leaflets in PostnCre;Ctnnb1fl/fl mice is in contrast to the results observed in cultured 
embryonic aVOCs and suggests that Wnt/β-catenin signaling is modulated by physiological 
factors in vivo. It has been reported that mechanical tension and compression stimulate the 
expression of Wnt10b, and co-receptor Lrp5 in cultured osteoblast cells.34 The intracellular 
mechanosensing RhoA/ROCK cascade also affects Sox9 expression and activity.35, 36 Thus 
mechanical stimulation may have a role in the interaction between Wnt/β-catenin signaling 
and Sox9-mediated chondrogenic differentiation in the aortic VICs.
Loss of β-catenin in VICs leads to increased expression and nuclear localization of Sox9, as 
well as increased expression of Col2a1, Acan, and Col10a1, in cultured aVOC and adult 
AoVs. This same regulatory hierarchy is active in hypertrophic cartilage,37–39 and loss of β-
catenin in mesenchymal progenitors leads to increased expression of Sox9 and ectopic 
cartilage formation in the developing skull.40, 41 Here, we demonstrate that loss of Wnt/β-
catenin signaling leads to increased nuclear localization of Sox9 and chondrogenic gene 
induction in valve progenitors and adult valves. Although Sox9 and β-catenin proteins have 
been demonstrated to interact in cartilage39, 42 and gonad development43, the mechanism by 
which loss of β-catenin leads to increased nuclear localization of Sox9 is not known. In 
developing valves, Sox9 is required for expression of cartilage-related ECM genes, 
including Hapln1 and Col2a1.20 Haploinsufficiency of Sox9 in heart valves is sufficient to 
promote ectopic calcification in adult mice,21 and Sox9 suppresses Osteopontin expression 
preventing matrix mineralization in postnatal mouse heart valve explants.22 Increased 
Wnt/β-catenin signaling has also been implicated in human calcific aortic valve disease, 
potentially by promoting active osteogenesis in the fibrosa layer.15, 44 Here, we show that 
loss of β-catenin leads to abnormal chondrogenic differentiation of aortic VICs with 
excessive accumulation of proteoglycans in mice. Likewise, nuclear Sox9 and Hapln1 
protein expression are increased in human myxomatous valve disease. Together, these data 
provide further evidence for shared regulatory mechanisms in skeletal lineages and in heart 
valve development and disease.1, 5, 6
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Excessive proteoglycan accumulation is one of the characteristics of myxomatous valve 
disease.1–4 Although its etiology appears complex, mutations in the cytoskeletal protein 
Filamin A (FLNA) and a variety of ECM protein mutations have been linked to human 
myxomatous valve disease.2, 3, 45–47 Additional causes include congenital malformation, 
increased serotonin signaling, or infective endocarditis.48 In each case, the myxomatous 
valve exhibits increased proteoglycan and decreased collagen composition leading to 
insufficiency and regurgitation. However, the molecular mechanism(s) of disease 
pathogenesis and progression are still poorly understood.3, 4 Expression of Aggrecan, Col2 
and Sox9 is induced in human myxomatous valve disease, suggesting that chondrogenic 
differentiation of VICs is integral to disease pathogenesis.24 Similarly, in mice lacking 
endogenous Postn, inappropriate differentiation of mesenchymal cushion cells and abnormal 
Aggrecan expression were detected in Postn−/− valves.49 Here, we demonstrate that VICs 
directly undergo chondrogenic differentiation with excessive proteoglycan accumulation as 
a result of loss of β-catenin. The chondrogenic nodules observed in mouse aortic valves are 
not a characteristic feature of human valve pathology. However predominant nuclear Sox9 
localization in regions of increased Hapln1 protein expression was observed in both 
PostnCre;Ctnnb1fl/fl AoV and human myxomatous mitral valve disease, supporting a role 
for this regulatory interaction in human valve pathogenesis. It remains to be determined if 
Wnt/β-catenin signaling is repressed by the multiple causes of myxomatous valve disease or 
contributes to pathogenesis that ultimately leads to valve insufficiency. If this is the case, 
maintaining or increasing Wnt/β-catenin signaling could be exploited therapeutically as an 
alternative to surgical repair, which is the current standard of care for severe myxomatous 
valve disease.3
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Significance
The role of Wnt/β-catenin signaling in heart valve stratification and subsequent 
extracellular matrix (ECM) maintenance is not known. In this study, we found that 
Wnt/β-catenin signaling is required for heart valve homeostasis, since loss of β-catenin 
leads to increased chondrogenic differentiation of aortic valve interstitial cells (VICs) in 
adult mice. In the absence of β-catenin, VICs are susceptible to ectopic chondrogenic 
differentiation, leading to the formation of nodules containing proteoglycan-rich 
hypertrophic cartilage-like cells, with nuclear localization of the chondrogenic 
transcription factor Sox9 and loss of fibrillar collagen. This chondrogenic phenotype is 
similar to human myxomatous heart valve disease characterized by increased nuclear 
Sox9 localization and excessive proteoglycan accumulation.
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Figure 1. Wnt/β-catenin signaling inhibits chondrogenic gene expression in chicken embryo 
aortic valve organ cultures (aVOC)
A–C. Sox9 expression (green) is shown by immunofluorescent staining in sectioned aVOCs 
after treatment with DMSO, BIO (Wnt activation) or XAV-939 (Wnt inhibition). 
Arrowheads indicate cells with positive nuclear Sox9 staining (orange) in A and C, whereas 
arrows in B indicate cells with cytosolic Sox9 (green). D–F. Aggrecan expression (green) is 
detected by immunofluorescent staining in treated aVOCs. Arrowheads indicate positive 
Aggrecan staining in both D and F. G–I. Col2 expression (green, arrowheads) is decreased 
in BIO-treated aVOCs (H), compared to either DMSO controls (G) or XAV-treated aVOCs 
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(I). Arrowheads indicate positive Col2 staining in both G and I. Nuclei are counterstained 
with Topro 3, and pseudo-colored in red (A–C), or blue (D–I). Representative images are 
shown from four aVOCs analyzed for each condition. J. Expression of the Wnt/β-catenin 
pathway target gene Axin2 and chondrogenic genes Sox9, Col2a1, Col10 and Aggrecan was 
evaluated by qRT-PCR in cultured aVOC treated with DMSO, BIO or XAV (n=6). 
Normalized relative gene expression levels were calculated and compared to DMSO 
controls that were set to 1.0. Statistical significance was determined using paired Student’s t-
tests. * indicates p<0.05. Error bars represent SEM.
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Figure 2. Wnt/β-catenin signaling is active in adult AoVs and loss of β-catenin leads to formation 
of proteoglycan-rich hypertrophic cartilage-like nodules in the AoVs of PostnCre;Ctnnb1fl/fl mice
A. Wnt/β-catenin signaling, as indicated by Axin2lacZ reporter activity, is active in the distal 
tip of a normal aortic valve (AoV) at 2 months-of-age. Arrows indicate cells with β-gal 
activity (blue) expressed from the Axin2lacZ locus in X-gal stained sections. B. PostnCre is 
active throughout the leaflets (arrows) of AoV, including the nodule (arrowheads), in 
PostnCre;Ctnnb1fl/fl;ROSA26 mice at 3 months of age. C, D. AoVs are stained by Movat’s 
Pentachrome to visualize the ECM distribution and morphology at 3 months. Arrows in C 
indicate normal valve stratification, whereas arrowheads in D indicate proteoglycan-rich 
Fang et al. Page 15
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2015 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(blue) nodules. E, F. AoVs were stained by Masson’s Trichrome for detection of collagen 
(blue) at 3 months of age (n=4). Arrows in E indicate normal collagen deposition, whereas 
arrowheads in F indicate collage expression surrounding the nodules.
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Figure 3. The nodular cells PostnCre;Ctnnb1fl/fl AoVs express nuclear Sox9
A, B. Sox9 expression (red) is shown in PostnCre;Ctnnb1fl/fl (LOF) nodular cells but is not 
detected (asterisk) in Cre-negative control (Ctrl) AoVs. The arrow in A indicates normal 
expression of Hapln1 (green) in controls. The arrowhead in B indicates the Hapln1-positive 
(green) LOF nodule, and strong nuclear Sox9 expression (red) in LOF nodular cells (arrows, 
inset in B). Nuclei are counterstained in blue by Topro3. Staining shown is representative of 
n=4 specimens analyzed, and a minimum of 2 different slides per sectioned sample was 
stained. C. Nuclear Sox9 (red) is shown at higher magnification within a Hapln1-positive 
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(green) nodule in a PostnCre;Ctnnb1fl/fl AoV. Arrows indicate nuclear Sox9 positive 
nodular cells. D. The percent of Sox9 positive nuclei is significantly higher in the LOF 
nodules than in control AoVs or perinodular regions (Hapln-negative) in LOF AoVs (LOF 
n=6, control n=8; ANOVA). # indicates p<0.01. n.s indicates not significant (p=0.401). 
Error bars represent SEM.
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Figure 4. PostnCre;Ctnnb1fl/fl nodular cells express chondrocyte markers Aggrecan, Col2 and 
ColX
A–I, Chondrogenic ECM genes are induced and expressed at high levels in 
PostnCre;Ctnnb1fl/fl (LOF) nodules compared to Cre-negative controls (Ctrl). Aggrecan (A, 
B, D & E; green), Col2 (D, E; red) and ColX (G, H; green) expression is shown in control 
AoVs and LOF nodules. Arrows indicate the lack of endogenous chondrogenic ECM 
expression in control AoV (A, D, and G), whereas arrowheads indicate induced expression 
in LOF nodules (B, E, and H). By qRT-PCR (C, F and I), Aggrecan (Acan), Col2a1 and 
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Col10a1 are significantly upregulated in LOF AoV, compared to Cre-negative controls 
(n=3). J, K. The relative distribution of Versican (green) and Halpn1 (red) expression is 
shown in LOF and control AoVs. Arrows indicate normal Versican expression and limited 
expression of Hapln1 in control AoVs (J). Arrowheads indicate markedly reduced Versican 
expression (green) and increased Hapln1 expression (red) in LOF nodules (K). L. By qRT-
PCR, Hapln1 is significantly increased in LOF AoV relative to controls, whereas Versican 
(Vcan) expression is decreased in LOF AoV compared to controls (n=3). Student’s t-tests 
were performed to determine the statistical significance of gene expression differences 
between LOF and control AoVs. # indicates p<0.01, and * indicates p<0.05. All error bars 
represent SEM.
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Figure 5. Fibrosa ECM markers Col1, Col3 and Postn are minimally expressed in the nodules 
but are present in the perinodular regions
A, B. Col1 expression is shown in PostnCre;Ctnnb1fl/fl (LOF) and Cre-negative control 
(Ctrl) AoVs. Arrows indicate normal Col1 expression (green) in the valve leaflets, and 
Hapln1 (red) restricted to the commissure in control AoVs (A). Arrowheads indicate that the 
Hapln1-positive (red) LOF nodules are Col1 negative, whereas arrows indicate Col1 
expression in perinodular regions in LOF AoVs (B). C–F. Similarly, the protein expression 
(green) of Col3 (C,D) and Postn (E,F) also is decreased in the Hapln1-positive nodules (red) 
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in LOF AoVs (arrowheads, D, F), compared to controls (arrows, C, E). G. By qRT-PCR, 
Col1a1 and Postn are significantly (n=3; # indicate p<0.01) decreased in LOF AoVs 
compared to Cre-negative controls as determine by Student’s t-est. However, no significant 
(n.s.) difference (p=0.438) is detected in Col3a1 expression between controls and LOF 
mutants. Error bars represent SEM.
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